By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Hypoglycemic synthetic and other drugs in combinations

Pharmaceutical group preparations

Substance Drugs
Alogliptin+Metformin
Alogliptin+Pioglitazone
Dapagliflozin+Metformin
Glibenclamide+Metformin | | | | | | | |
Gliclazide+Metformin
Glimepiride+Metformin |
Glimepiride+Rosiglitazone
Gosogliptine and Metformin
Linagliptin+Empagliflozin
Linagliptin+Metformin
Metformin and Sibutramine+[Cellulose microcrystallic] [set]
Metformin+Empagliflozin
Metformin+Glibenclamide
Metformin+Glipizide
Metformin+Rosiglitazone
Metformin+Saxagliptin
Metformin+Sibutramine
Metformin+Sitagliptin | | | | |
Metformin+[Sibutramine+Cellulose microcrystallic]
Vildagliptin+Metformin | | |
The active substance is not described |

Tree of pharmacological groups

Description

There is no detailed description, see related
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.